The evidence supporting GLP-1 medications is robust, but the distinction between short-term symptom management and long-term weight control remains clinically important
Tretzel L, Thomas A, Piper T, Hedeland M, Geyer H, Schnzer W, et al
Furthermore, both TRF and probiotic/postbiotic interventions should be comprehensively evaluated based on individual genetic background, lifestyle, underlying diseases, and other factors
Glutathione is a tripeptide produced by the body and is involved in maintaining normal cellular function
The TRIUMPH programme will investigate retatrutide in people with obesity and the TRANSCEND-T2D programme is investigating retatrutide in people with T2D and overweight/obesity